Neonious Biotech

Neonious Biotech

Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
Pre-ICO
25 Mei 2021
31 Okt 2021
100% lengkap
Mengumpulkan dana - tanpa data
Tujuan 250 000.00 USD
Topi 30 000 000.00 USD
past
  • 1 MDSIM
    =
    0.1 USD
Detail Token
Jantung
MDSIM
Total pasokan
125000000
Distribusi Token
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
Mata Uang yang Diterima
ETH, USDC
Kontribusi Min
250000
USD
Detail Perusahaan
Nama Perusahaan Terdaftar
Neonious Biotech
Negara Terdaftar
Germany
Struktur Bonus
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
detil tambahan
MVP / Prototipe
iya nih
Peron
Ethereum
Negara yang Dibatasi
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
Kategori
Peron

Tentang Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

Info Teknis

https://github.com/neonious/WelcomeToCodeRepository

% name% Roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • Baca lebih banyak
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Neonious Biotech Tim

Diverifikasi 0%

Perhatian. Ada risiko bahwa anggota yang tidak diverifikasi sebenarnya bukan anggota tim

Thomas Rogg
Chief Executive Officer & Head of Development Team
tidak diverifikasi
Elena Elgina
Head of PR & Marketing
tidak diverifikasi
Maria Cristina Fadgy...
Head of Scientific Affairs
tidak diverifikasi
Martin Kämpf
Head of Digital Assets
tidak diverifikasi

Neonious Biotech Berita terakhir

  • Karena mungkin ada perbedaan waktu dalam pembaruan informasi, informasi akurat tentang setiap proyek ICO harus diverifikasi melalui situs resminya atau saluran komunikasi lainnya.
  • Informasi ini bukan saran atau saran tentang berinvestasi dalam pendanaan ICO. Silakan teliti sendiri informasi yang relevan dan putuskan partisipasi ICO.
  • Jika Anda merasa ada masalah atau masalah yang harus diperbaiki pada konten ini, atau jika Anda ingin mengirimkan proyek ICO Anda sendiri untuk dicantumkan, Harap email kami.
Silahkan baca disclaimer dan risk warning. Tampilkan disclaimer dan risk warning.